The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
Open accessAbstract
Background & aims Irritable bowel syndrome (IBS) is a significant gastrointestinal disorder with unknown etiology. The symptoms can greatly weaken patients' quality of life and account for notable economical costs for society. Contribution of the gastrointestinal microbiota in IBS has been suggested. Our objective was to characterize putative differences in gastrointestinal microbiota between patients with IBS and control subjects. These differences could potentially have a causal relationship with the syndrome.Methods Microbial genomes from fecal samples of 24 patients with IBS and 23 controls were collected, pooled in a groupwise manner, and fractionated according to their guanine cytosine content. Selected fractions were analyzed by extensive high-throughput 16S ribosomal RNA gene cloning and sequencing of 3753 clones. Some of the revealed phylogenetic differences were further confirmed by quantitative polymerase chain reaction assays on individual samples.Results The coverage of the clone libraries of IBS subtypes and control subjects differed significantly (P < .0253). The samples were also distinguishable by the Bayesian analysis of bacterial population structure. Moreover, significant (P < .05) differences between the clone libraries were found in several bacterial genera, which could be verified by quantitative polymerase chain reaction assays of phylotypes belonging to the genera Coprococcus, Collinsella, and Coprobacillus.Conclusions The study showed that fecal microbiota is significantly altered in IBS. Further studies on molecular mechanisms underlying these alterations are needed to elucidate the exact role of intestinal bacteria in IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“others have shown that the colonic microbiome is altered in patients with IBS, when compared with healthy controls. 15 - 18”
From Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis (2023) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The faecal microbiome of patients with IBS may differ significantly from that of healthy individuals.216”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [216]
In the citing paper
“The consortium and dose used in this study had previously proved effective in both prevention of Clostridium difficile in vivo 8,9 and the modulation of the composition of the intestinal re-growth population following antibiotic therapy.10,11”
In the citing paper
“Kassinen et al. 8 have shown that both the lactobacillus and the bifidobacterial components of the microbiota of IBS sufferers were present in lower numbers than in the controls suggesting a value for intervention strategies comprising both organisms.”
In the citing paper
“Imbalanced microbiota may be one such factor, as deviations in microbiota have been seen in IBS 23-25 and as studies on inflammatory bowel disease imply that the microbiota is able to trigger mucosal inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [25]
In the citing paper
“A stabilization of the microbiota composition may be particularly important in IBS, as no single deviance has been identified in IBS microbiota, but various alterations in the bacterial composition have been characterized. 23-25, 35”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [25]
In the citing paper
“Recent studies using these advanced molecular biology techniques have demonstrated quantitative alterations of specific bacterial groups (33, 34, 81, 85, 142, 154) and reduced diversity in gut microbial populations in patients with IBS compared with healthy controls (33, 40).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [85]
In the citing paper
“Elevations in the Firmicutes:Bacteroidetes ratio have been associated with a high-fat diet and obesity[274,328,329], irritable bowel syndrome[330], hypertension[331], type 1 diabetes[276], and HIV[332].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [330]
In the citing paper
“A departure from the physiological balance of the enteric microbiota has been suggested as a factor in the pathophysiology of IBS, a condition in which abnormal gastrointestinal motility and secretion is implicated as a cause of alterations in bowel habits.79”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [79]
In the citing paper
“A departure from the physiological balance of the enteric microbiota has been suggested as a factor in the pathophysiology of IBS, a condition in which abnormal gastrointestinal motility and secretion is implicated as a cause of alterations in bowel habits.79”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,714
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Multiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,905
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
THE POPULATION FREQUENCIES OF SPECIES AND THE ESTIMATION OF POPULATION PARAMETERS
Good, I. J. (1953) · Biometrika · doi:10.1093/biomet/40.3-4.237 · Cited by 3,427
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
Editorial: Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All?
Schmulson, M. J., & Chey, W. D. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.427 · Cited by 34
Nelson, T. A., Holmes, S., Alekseyenko, A. V., Shenoy, M. M., DeSantis, T. Z., Wu, C. H., Andersen, G. L., Winston, J. H., Sonnenburg, J. L., Pasricha, P. J., et al. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01637.x · Cited by 33
Han, K., Wang, J., Seo, J., & Kim, H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1224-y · Cited by 35
Šmid, A., Strniša, L., Bajc, K., Vujić-Podlipec, D., Matijašić, B. B., & Rogelj, I. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.04.031 · Cited by 37
Quagliariello, A., CHIERICO, F. D., Reddel, S., Russo, A., Muda, A. O., D’Argenio, P., Angelino, G., Romeo, E. F., Dall’Oglio, L., Angelis, P. D., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8101486 · Cited by 33
Brereton, N. J. B., Pitre, F. E., & González, E. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.040 · Cited by 35
Wu, J. C. Y. (2010) · PubMed Central · Cited by 32
Farup, P. G., Jacobsen, M., Ligaarden, S. C., & Rudi, K. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/214102 · Cited by 33
Irritable Bowel Syndrome: Shifting the Focus Toward the Gut Microbiota
Shanahan, F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.030 · Cited by 33
Effects of Human Milk Oligosaccharides in Infant Health Based on Gut Microbiota Alteration
Hu, M., Li, M., Li, C., Miao, M., & Zhang, T. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05734 · Cited by 34
Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health
Lavelle, A., Lennon, G., Docherty, N. G., Balfe, Á., Mulcahy, H. E., Doherty, G. A., O’Donoghue, D. P., Hyland, J. M., Shanahan, F., Sheahan, K. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078835 · Cited by 31
The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome
ak, E. K. C., Akbal, E., Köklü, S., l, B. E. U., & Can, M. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5716 · Cited by 32
Immune Activation in Functional Gastrointestinal Disorders.
Burns, G. L., Pryor, J., Holtmann, G., Walker, M. M., Talley, N. J., & Keely, S. (2019) · PubMed Central · Cited by 32
Jalanka, J., Gunn, D., Singh, G., Krishnasamy, S., Lingaya, M. R., Crispie, F., Finnegan, L., Cotter, P. D., James, L., Nowak, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326828 · Cited by 32
The Families Erysipelotrichaceae emend., Coprobacillaceae fam. nov., and Turicibacteraceae fam. nov.
Verbarg, S., Göker, M., Scheuner, C., Schümann, P., & Stackebrandt, E. S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30120-9_205 · Cited by 32
Britton, L., Cassidy, J. P., O’Donovan, J., Gordon, S. V., & Markey, B. K. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.10.033 · Cited by 32
Methodological issues in the study of intestinal microbiota in irritable bowel syndrome.
Taverniti, V., & Guglielmetti, S. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8821 · Cited by 32
Bazzocchi, G., Giovannini, T., Giussani, C., Brigidi, P., & Turroni, S. (2014) · Techniques in Coloproctology · doi:10.1007/s10151-014-1201-5 · Cited by 32
Gophna, U. (2011) · Science · doi:10.1126/science.1213799 · Cited by 31
Ju, X., Jiang, Z., Ma, J., & Yang, D. J. (2024) · Nutrients · doi:10.3390/nu16111727 · Cited by 38
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents
Sainsbury, A., & Ford, A. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10387203 · Cited by 36
Fecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders
Heath, R. D. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.10692 · Cited by 32
Zyoud, S. H., Smale, S., Waring, W. S., Sweileh, W. M., & Al‐Jabi, S. W. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i13.1341 · Cited by 31
Alterations in intestinal microbiota in ultramarathon runners
Sato, M., & Suzuki, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-10791-y · Cited by 30
Pimentel, M., & Chang, C. C.-C. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.010 · Cited by 30
Cash, B. D., Pimentel, M., Rao, S. S. C., Weinstock, L. B., Chang, L., Heimanson, Z., & Lembo, A. J. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17726087 · Cited by 31
Irritable bowel syndrome: a new therapeutic target when treating obesity?
Pugliese, G., Muscogiuri, G., Barrea, L., Laudisio, D., Savastano, S., & Colao, A. (2019) · HORMONES · doi:10.1007/s42000-019-00113-9 · Cited by 30
Marin, T., Maxel, X., Robin, A., & Stubbe, L. (2020) · EXPLORE · doi:10.1016/j.explore.2020.09.006 · Cited by 31
Govaert, M., Rotsaert, C., Vannieuwenhuyse, C., Duysburgh, C., Medlin, S., Marzorati, M., & Jarrett, H. (2024) · Nutrients · doi:10.3390/nu16162791 · Cited by 35
Garcia-Mansilla, M. J., Rodríguez‐Sojo, M. J., Lista, A. R., Mosqueda, C. V. A., Ruiz‐Malagón, A. J., Gálvez, J., Rodríguez‐Nogales, A., & Rodríguez, M. J. (2024) · Nutrients · doi:10.3390/nu17010155 · Cited by 31
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview
Bokic, T., Storr, M., & Schicho, R. (2015) · Pharmacology · doi:10.1159/000435816 · Cited by 30
Aoki, R., Fukuda, K., Ogawa, M., Ikeno, T., Kondo, H., Tawara, A., & Taniguchi, H. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.001 · Cited by 29
Mind the gut: probiotics in paediatric neurogastroenterology
Salvatore, S., Pensabene, L., Borrelli, O., Saps, M., Thapar, N., Concolino, D., Staiano, A., & Vandenplas, Y. (2018) · Beneficial Microbes · doi:10.3920/bm2018.0013 · Cited by 30
Yang, M. J., Hong, G., Jin, Y. T., Li, Y., Li, G., & Hou, X. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.515614 · Cited by 28
Intestinal protozoan infections shape fecal bacterial microbiota in children from Guinea-Bissau
von Huth, S., Thingholm, L. B., Kofoed, P., Bang, C., Rühlemann, M. C., Franke, A., & Holmskov, U. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009232 · Cited by 28
Fernández, L. M. B., Man, F., & Lasa, J. S. (2023) · Digestive Diseases · doi:10.1159/000528954 · Cited by 29
Konstantis, G., Efstathiou, S., Pourzitaki, C., Kitsikidou, E., Germanidis, G. S., & Chourdakis, M. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.019 · Cited by 31
Natural Useful Therapeutic Products from Microbes
Gupta, C. (2014) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2014.01.00006 · Cited by 29
Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients
Öhman, L., Lindmark, A.-C., Isaksson, S., Posserud, I., Strid, H., Sjövall, H., & Simrén, M. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283503f39 · Cited by 31
Le microbiote intestinal et la digestion des polysaccharides
Kaoutari, A. E., Armougom, F., Raoult, D., & Henrissat, B. (2014) · médecine/sciences · doi:10.1051/medsci/20143003013 · Cited by 39
Schmulson, M., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López-Colombo, A., López Vidal, Y., Peláez-Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.01.004 · Cited by 29
Probiotic Bacteria and Enteric Infections
Paton, A., Morona, R., & Paton, J. (2011) · Springer eBooks · doi:10.1007/978-94-007-0386-5 · Cited by 30
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders
Lee, H. J., Choi, J., Ryu, H. S., Choi, C. H., Kang, E. H., Park, K. S., Min, Y. W., & Hong, K. S. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16124 · Cited by 29
Differences in Gut Microbiota Between Atopic and Healthy Children
Drell, T., Larionova, A., Voor, T., Simm, J., Julge, K., Heilman, K., Tillmann, V., Štšepetova, J., & Sepp, E. (2015) · Current Microbiology · doi:10.1007/s00284-015-0815-9 · Cited by 30
Chen, L., Tai, W., Brar, M. S., Leung, F. C.-C., & Hsiao, W. L. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126807 · Cited by 29
Sharma, A. K., Petrželková, K. J., Pafčo, B., Robinson, C. A. J., Fuh, T. N., Wilson, B. A., Stumpf, R. M., Torralba, M., Blekhman, R., White, B. A., et al. (2020) · mSystems · doi:10.1128/msystems.00815-20 · Cited by 28
Probiotics in personal care products
Huang, M. J., & Tang, J. (2015) · Microbiology Discovery · doi:10.7243/2052-6180-3-5 · Cited by 27
Wells, M. M., Roth, L., & Chande, N. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.486 · Cited by 27
Bahrudin, M. F., Rani, R. A., Tamil, A. M., Mokhtar, N. M., & Ali, R. A. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05695-3 · Cited by 28
Miyazato, S., Kishimoto, Y., Takahashi, K., Kaminogawa, S., & Hosono, A. (2015) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2015-009 · Cited by 26
Shutkever, O., Gracie, D. J., Young, C., Wood, H. M., Taylor, M., Hamlin, P. J., Ford, A. C., & Quirke, P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy052 · Cited by 26
Irritable bowel syndrome: diagnostic approaches in clinical practice
Burbige (2010) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s12596 · Cited by 24
Le microbiote intestinal humain
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70002-6 · Cited by 25
THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review
Moraes-Filho, J. P. P., & Quigley, E. M. M. (2015) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032015000400015 · Cited by 25
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation
Ponziani, F. R., Pecere, S., Lopetuso, L. R., Scaldaferri, F., Cammarota, G., & Gasbarrini, A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1186639 · Cited by 24
Wiley, J. W., & Chang, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.014 · Cited by 25
New molecular insights into inflammatory bowel disease-induced diarrhea
Tang, Y., Forsyth, C. B., & Keshavarzian, A. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.64 · Cited by 26
Kwon, H., Nam, E. H., Kim, H., Jo, H.-N., Bang, W. Y., Lee, M., Shin, H., Kim, D., Kim, J. H., Kim, H.-J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72887-x · Cited by 32
Consenso mexicano sobre el síndrome de intestino irritable
Carmona-Sánchez, R., Icaza-Chávez, M. E., Bielsa-Fernández, M. V., Gomez-Escudero, O., Bosques‐Padilla, F., Coss‐Adame, E., Esquivel-Ayanegui, F., Flores-Rendón, Á. R., González-Martínez, M. A., Huerta-Iga, F. M., et al. (2016) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2016.01.004 · Cited by 26
Survey of (Meta)genomic Approaches for Understanding Microbial Community Dynamics
Sharma, A., & Lal, R. (2016) · Indian Journal of Microbiology · doi:10.1007/s12088-016-0629-x · Cited by 24
Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome
Barboza, J., Talley, N. J., & Moshiree, B. (2014) · Drugs · doi:10.1007/s40265-014-0292-7 · Cited by 24
Probiotics and Irritable Bowel Syndrome
Barbara, G., Stanghellini, V., Cremon, C., GIORGIO, R. D., Gargano, L., Cogliandro, R. F., Pallotti, F., & Corinaldesi, R. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817da129 · Cited by 24
Kanauchi (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000376 · Cited by 24
Gu, Q., Zhang, J., & Feng, Y. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1111238 · Cited by 24
Ganji, L., Alebouyeh, M., Shirazi, M. H., Ss, E., Mirshafiey, A., Naser, E. D., & Zali, M. R. (2016) · Gastroenterology and hepatology from bed to bench. · Cited by 24
Wan, J., Jing, Y., Rao, Y., Zhang, S., & Luo, G. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02632-17 · Cited by 24
Review: Do probiotics improve symptoms in patients with irritable bowel syndrome?
Whorwell, P. J. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09335637 · Cited by 23
Gut Microbiome and the Role of Metabolites in the Study of Graves’ Disease
Liu, H., Liu, H., Liu, C., Shang, M., Wei, T., & Yin, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841223 · Cited by 24
The Gut Microbiota and Chronic Pain
Pak, R. J., Cho, M. S., Pride, K., & Abd-Elsayed, A. A. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01221-x · Cited by 23
Katiraei, P., & Bultron, G. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2791 · Cited by 27
Faghihi, A. H., Agah, S., Masoudi, M., Ghafoori, S. M. S., & Eshraghi, A. (2015) · Acta medica Indonesiana · Cited by 22
Mazzawi, T. R. E., & El‐Salhy, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3096 · Cited by 23
Aguilera‐Lizarraga, J., Florens, M. V., Brussel, T. V., Clevers, E., Oudenhove, L. V., Lambrechts, D., Wouters, M. M., & Boeckxstaens, G. E. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13579 · Cited by 23
Exploring the Genetic Diversity of the 16S rRNA Gene of Akkermansia Muciniphila in IBD and IBS
Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Cella, E., Putignani, L., Guarino, M. P. L., Monteleone, G., Cicala, M., Angeletti, S., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0175 · Cited by 25
Malone, M. (2011) · Primary Care · doi:10.1016/j.pop.2011.05.003 · Cited by 7
Bora, G., Atkinson, S. N., Pan, A., Sood, M., Salzman, N. H., & Karrento, K. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13203 · Cited by 22
El‐Salhy, M., Lillebø, E., Reinemo, A., Salmelid, L., & Hausken, T. (2010) · Gastroenterology Insights · doi:10.4081/gi.2010.e6 · Cited by 22
Irritable bowel syndrome; update on pathophysiology and management
Quigley, E. M. M., & Craig, O. F. (2012) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2012.0551 · Cited by 22
The Predictive Value of the Hydrogen Breath Test in the Diagnosis of Fructose Malabsorption
Helwig, U., Koch, A. K., Koppka, N., Holtmann, S., & Langhorst, J. (2018) · Digestion · doi:10.1159/000489877 · Cited by 22
Microbial dysbiosis in irritable bowel syndrome: A single‐center metagenomic study in Saudi Arabia
Masoodi, I., Alshanqeeti, A. S., Alyamani, E. J., Al-Lehibi, A. A., Alqutub, A. N., Alsayari, K. N., & Al-Omair, A. (2020) · JGH Open · doi:10.1002/jgh3.12313 · Cited by 22
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
Rodrigues, T., Fialho, S. R., Araújo, J. R., Rocha, R., & Moreira-Rosário, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051725 · Cited by 21
Bacterial Flora as a Cause or Treatment of Chronic Diarrhea
Scaldaferri, F., Pizzoferrato, M., Pecere, S., Forte, F., & Gasbarrini, A. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.06.002 · Cited by 21
Cash, B. D., Lacy, B. E., Rao, T., & Earnest, D. L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1118052 · Cited by 21
Close association between intestinal microbiota and irritable bowel syndrome
Fan, W.-T., Ding, C., Xu, N., Zong, S., Ma, P., & Gu, B. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3060-2 · Cited by 24
Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
Vork, L., Penders, J., Jalanka, J., Bojić, S., van Kuijk, S. M. J., Salonen, A., de Vos, W. M., Rajilić-Stojanović, M. D., Weerts, Z. Z. R. M., Masclee, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.639667 · Cited by 18
Land, B. V., Schijf, M. A., Martín, R., Garssen, J., & van Bleek, G. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.082 · Cited by 21
Profile of rifaximin and its potential in the treatment of irritable bowel syndrome
Schey, R., Iorio, N., & Malik, Z. A. (2015) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s67231 · Cited by 21
Rodríguez, Ó., Hernández-Ruiz, J., López‐Vidal, Y., Charúa-Guindic, L., Bandeh-Moghaddam, H., Minzoni, A., Guzmán, C., & Schmulson, M. J. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12204 · Cited by 20
Huys, G. R. B., Vanhoutte, T., & Vandamme, P. A. R. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/597603 · Cited by 20
Carriage of Clostridium difficile in outpatients with irritable bowel syndrome
Clayton, E. M., Rea, M. C., Shanahan, F., Quigley, E. M. M., Kiely, B., Ross, R. P., & Hill, C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.040568-0 · Cited by 19
Overgrowth of the indigenous gut microbiome and irritable bowel syndrome
Bye, W. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2449 · Cited by 19
Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes
Weaver, M. J., Mchenry, S. A., Sayuk, G. S., Gyawali, C. P., & Davidson, N. O. (2020) · Hepatology Communications · doi:10.1002/hep4.1485 · Cited by 19
Mottawea, W., Sultan, S., Landau, K., Bordenave, N., & Hammami, R. (2020) · Nutrients · doi:10.3390/nu12092669 · Cited by 21
Seong, G., Lee, S., Min, Y., Jang, Y., Park, S.-Y., Kim, C.-H., Lee, C., Hong, S., & Chang, D. (2020) · Nutrients · doi:10.3390/nu12103205 · Cited by 17
Microbiota and the irritable bowel syndrome
Sabo, C. M., & DUMITRASCU, D. L. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02923-5 · Cited by 21
Mazzawi, T. R. E., Hausken, T., Refsnes, P. F., Hatlebakk, J. G., & Lied, G. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091819 · Cited by 20
Przewłócka, K., Folwarski, M., Kaczmarczyk, M., Skonieczna‐Żydecka, K., Palma, J., Bytowska, Z. K., Kujach, S., & Kaczor, J. J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1256226 · Cited by 20
Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review
El-Ghannam, M., Hassanien, M. H., Ameen, Y. A., Turky, E. A., ELattar, G. M., Ray, A. A. E., & Eltalkawy, M. D. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00340-9 · Cited by 20
Azarfarin, M., Moradikor, N., Matin, S., & Dadkhah, M. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.70009 · Cited by 20
Metadata
- Authors
- Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Palva, Airi
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 133
- Issue
- 1
- Pages
- 24-33
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2024601462
- Cited by
- 1,002
- References
- 53
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 44 · 2023: 40 · 2022: 46 · 2021: 47 · 2020: 40 · 2019: 61 · 2018: 57 · 2017: 55 · 2016: 67 · 2015: 63 · 2014: 83 · 2013: 66 · 2012: 78
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, fecal microbiota, gut microbiota, 16S rRNA gene sequencing, bacterial population structure, Coprococcus, Collinsella, Coprobacillus, IBS subtypes, bacterial phylotypes
- MeSH terms
- Adult, Aged, Bacteria, Base Composition, Bayes Theorem, Cloning, Molecular, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Phylogeny, RNA, Ribosomal, 16S, Gene Library, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
